Medine.co.uk

Naratriptan 2.5mg Tablets

Informations for option: Naratriptan 2.5mg Tablets, show other option
Document: leaflet MAH BRAND_PLPI 19488-1455 change

S1455 Naramig Leaflet 20150602

PACKAGE LEAFLET: INFORMATION FOR THE USER NARAMIG 2.5mg TABLETS NARATRIPTAN 2.5mg TABLETS (naratriptan hydrochloride)

Your medicine is known as the above names but will be referred to as Naramig throughout the following patient information leaflet.

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

1    What Naramig is and what it is used for

2    What you need to know before you take Naramig

3    How to take Naramig

4    Possible side effects

5    How to store Naramig

6    Contents of the pack and other information

1. WHAT NARAMIG IS AND WHAT IT IS USED FOR

Naramig contains naratriptan (hydrochloride), which belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists).

Naramig is used to treat migraine.

Migraine symptoms may be caused by the temporary widening of blood vessels in the head. Naramig is believed to reduce the widening of these blood vessels. This in turn helps to take away the headache and relieve other symptoms of a migraine attack, such as feeling or being sick (nausea or vomiting) and sensitivity to light and sound.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE NARAMIG

Do not take Naramig:

•    If you are allergic to naratriptan, or any of the other ingredients of this medicine (listed in section 6)

•    If you have a heart problem such as heart failure or chest pains (angina), or have already had a heart attack

•    If you have circulation problems in your legs that cause cramp-like pains when you walk (peripheral vascular disease)

•    If you have had a stroke or a mini-stroke (also called a transient ischaemic attack or TIA)

•    If you have high blood pressure. You may be able to take Naramig if your high blood pressure is mild and is being treated.

•    If you have kidney or liver disease

•    With other migraine medicines, including those which contain ergotamine, or with similar medicines such as methysergide, or with other 5-HT1 receptor agonists, such as sumatriptan.

If any of these apply to you:

^ Tell your doctor, and don't take Naramig.

Warnings and precautions

Talk to your doctor or pharmacist before taking Naramig.

If you have any extra risk factors

•    If you are a heavy smoker or are using nicotine replacement therapy, and especially

•    If you are a man over 40, or

•    If you are a woman who has been through the menopause.

In very rare cases, people have developed serious heart conditions after taking Naramig, even though they had no signs of heart disease before.

If any of the points in the list applies to you, it could mean you have a greater risk of developing heart disease - so:

^ Tell your doctor so that your heart function can be checked

before Naramig is prescribed for you.

If you are allergic to antibiotics called sulphonamides

If so, you may also be allergic to Naramig. If you know you are allergic to an antibiotic but you are not sure whether it is a sulphonamide:

^ Tell your doctor or pharmacist before taking Naramig.

If you take Naramig frequently

Taking Naramig too often may make your headaches worse.

^ Tell your doctor if this applies to you. He or she may

recommend you stop taking Naramig.

If you feel pain or tightness in your chest after you take Naramig

These effects may be intense but they usually pass quickly. If they don't pass quickly, or they become severe:

^ Get medical help immediately. Section 4 of this leaflet has more information about these possible side effects.

Not for older people or children under 18

Naramig is not recommended for people aged over 65 or for

children under the age of 18.

Other medicines and Naramig

Tell your doctor if you’re taking, have recently taken or might take any other medicines.

Some medicines must not be taken with Naramig and others may cause adverse effects if they're taken with Naramig. You must tell your doctor if you are taking:

•    any medicines for your migraine which contain any triptan/ 5-HTi agonist (such as sumatriptan or zolmitriptan). Don't take Naramig at the same time as these medicines. Stop taking these medicines at least 24 hours before taking Naramig.

•    ergotamine also used to treat migraine or similar medicines such as methysergide. Don't take Naramig at the same time as these medicines. Stop taking these medicines at least 24 hours before taking Naramig.

•    any antidepressants classed as selective serotonin reuptake inhibitors (SSRIs), such as citalopram, fluoxetine or paroxetine, or serotonin noradrenaline reuptake inhibitors (SNRIs) such as venlafaxine. If you are not sure, talk to your doctor or pharmacist.

•    St John’s Wort (Hypericum perforatum). Using herbal remedies that contain St John's Wort while you are taking Naramig may make side effects more likely.

Pregnancy and breast-feeding

•    If you are pregnant, think you may be pregnant or are planning to have a baby ask your doctor for advice before taking this medicine. There is only limited information about the safety of Naramig for pregnant women, though up till now there is no evidence of any increased risk of birth defects. Your doctor may recommend that you do not take Naramig while you are pregnant.

•    Don’t breast-feed your baby for 24 hours after taking Naramig. If you express any breast milk during this time, discard the milk and don't give it to your baby.

Driving and using machines

•    Either the symptoms of migraine or your medicine may make you drowsy. If you are affected, don’t drive or operate machinery.

Naramig contains lactose

Naramig tablets contain a small amount of a sugar called lactose. If you have an intolerance to lactose or any other sugars:

^ Ask your doctor for advice about taking Naramig.

3. HOW TO TAKE NARAMIG

Only take Naramig after your migraine headache begins.

Don’t take Naramig to try to prevent an attack.

Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

How much to take

•    The usual dose for adults aged 18 to 65 is one Naramig 2.5 mg tablet, swallowed whole with water.

Naramig is not recommended for children under 18 and adults over 65.

When to take Naramig

•    It’s best to take Naramig as soon as you feel a migraine coming on, although it can be taken at any time during an attack.

If your symptoms start to come back

•    You can take a second Naramig tablet after 4 hours, unless you have kidney or liver damage.

•    If you have kidney or liver damage don't take more than one tablet in 24 hours.

•    No one should take more than two tablets in 24 hours.

If the first tablet has no effect

•    Don’t take a second tablet for the same attack.

If Naramig doesn't give you any relief:

^ Ask your doctor or pharmacist for advice.

If you take more Naramig than you should

•    Don’t take more than two Naramig tablets in 24 hours.

Taking too much Naramig could make you ill. If you have taken more than two tablets in 24 hours:

^ Contact your doctor for advice.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor straight away if you notice any of the following serious side effects - you may need urgent medical treatment:

•    Heartbeat may go faster, slower or change rhythm (affects up to 1 in 100 people).

•    Pain in the lower left side of the stomach and bloody diarrhoea (ischaemic colitis - affects up to 1 in 1,000 people).

•    Allergic reaction (affects up to 1 in 1,000 people). The signs of allergy include rash; hives; itching; wheezing; swollen eyelids, face or lips; complete collapse.

If you get any of these symptoms soon after taking Naramig:

^ Don’t take any more. Contact a doctor straight away.

•    Heaviness, pressure, tightness or pain in the chest, throat or other parts of the body (affects up to 1 in 100 people). These effects may be intense but generally pass quickly.

If these effects continue or become severe (especially the chest pain):

^ Get medical help urgently. In a very small number of people these symptoms can be caused by a heart attack.

Common:

may affect up to 1 in 10 people

•    Feeling sick (nausea) or being sick (vomiting), although this may be due to the migraine itself.

•    Tiredness, drowsiness, or sleepiness (somnolence), or generally feeling unwell.

•    Dizziness, tingling feelings or getting hot flushes.

If you get any of these effects:

^ Tell your doctor or pharmacist.

Uncommon:

may affect up to 1 in 100 people

•    Visual disturbances (although these may be due to the migraine attack itself).

•    Slight increase in blood pressure which may occur up to 12 hours after taking Naramig.

If you get any of these effects:

^ Tell your doctor or pharmacist.

Very rare:

may affect up to 1 in 10,000 people

•    Heart problems, including chest pains (angina) and heart attack.

•    Poor blood circulation to the arms and legs, causing pain and discomfort.

If you get these symptoms:

^ Tell your doctor or pharmacist.

If you get side effects

If you notice any unwanted effects, even ones not listed in this leaflet, or if any of the side effects becomes troublesome:

^ Tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE NARAMIG

•    Do not store your tablets above 30°C.

•    KEEP OUT OF THE SIGHT AND REACH OF CHILDREN.

•    Do not use Naramig after the expiry date which is stated on the carton and blister strip. The expiry date refers to the last day of that month.

•    Tablets should not be thrown in your bin or put down the drain. If they are out of date, or no longer suitable for you, return them to your pharmacist.

•    If the medicine becomes discoloured or shows any other signs of deterioration, you should seek the advice of your pharmacist who will tell you what to do.

6. FURTHER INFORMATION

What Naramig contains

•    The active substance in Naramig is naratriptan.

Each Naramig film-coated tablet contains naratriptan equivalent to 2.5mg of naratriptan (as the hydrochloride).

•    The other ingredients are: microcrystalline cellulose, anhydrous lactose, croscarmellose sodium, magnesium stearate, hypromellose, titanium dioxide (E171), triacetin, yellow iron oxide (E172) and indigo carmine aluminium lake (E132).

What Naramig looks like and contents of the pack

Naramig tablets are pale green, D-shaped, film-coated tablets marked ‘GXCE5' on one side and plain on the other.

Naramig is available as blister packs of 4 or 12 tablets.

Additional Information

Pharmaceutical Companies are not allowed to answer questions from patients about their diseases. There are two national organisations, which offer both help and advice on migraine:

Migraine Action Association, Unit 6, Oakley Hay Lodge Business Park, Great Folds Road, Great Oakley, Northants NN18 9AS, Telephone: 01536 461333

The Migraine Trust, 55-56 Russell Square, London WC1B 4HP, Telephone: 020 7436 1336

You may be able to find out more about prescribed medicines from books in public libraries.

Product Licence holder

Procured from within the EU and repackaged by the Parallel Import Product Licence holder: S&M Medical Ltd, Chemilines House, Alperton Lane, Wembley, HA0 1DX.

Manufacturer

This product is manufactured by: Glaxo Wellcome Operations, Ware, UK.

I POM I PL No: 19488/1455

Leaflet revision date: 2 June 2015

Naramig is a registered trade mark of Glaxo Group Ltd, UK.

S1455 Naramig Leaflet 20150602